Bank of Montreal
PAND

Bank of Montreal’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Bank of Montreal’s Portfolio PAND Stock Details PAND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-370
Closed -$22K – 5522
2021
Q1 		$22K Sell
370
-794
-68% -$28.7K ﹤0.01% 4021
2020
Q4 		$20K Buy
1,164
+818
+236% +$11.4K ﹤0.01% 4427
2020
Q3 		$4K Buy
+346
New +$5.91K ﹤0.01% 4559

Bank of Montreal's PAND Position: Q2 2021 in Review

Bank of Montreal sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 370 shares — an estimated $22K sold.

Bank of Montreal first reported a position in PAND in Q3 2020 and held it in 3 quarters. The position peaked at $22K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

  • Bank of Montreal reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 370 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $22K.
  • Bank of Montreal first reported a position in Pandion Therapeutics Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Bank of Montreal's Pandion Therapeutics Inc. Common Stock position peaked at $22K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.